Generic Drugs


Generic Drugs Market Research Reports Analysis and Trends

Publication Single User License (PDF) Price
Generics in the Antivirals Market to 2018 - Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will Drive Volume Growth

Generics in the Antivirals Market to 2018 - Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will Drive Volume Growth

Date Published: Jun 25 2012
Generics in the Antivirals Market to 2018 Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will Drive Volume Growth” report describes generic market in antiviral therapeutics. This report covers antiviral therapeutics including HIV therapeutics, Hepatitis therapeutics, Herpes therapeutics, CMV therapeutics and Influenza therapeutics.
Generics in the Antivirals Market was estimated at $4.2 billion in 2010 and is expected to reach to $9.2 billion in 2018.
 
$3,500.00
Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs

Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs

Date Published: Dec 14 2012
$3,500.00
Generic and innovative drugs market in Central Europe 2013

Generic and innovative drugs market in Central Europe 2013

Date Published: May 1 2013

Compare generic & innovative drug markets across Central Europe.
Report studies reimbursement regulations; forecasts market growth for 2013-2015.

$3,500.00
Generic and innovative drugs market in CIS countries 2013 : Russia, Ukraine and Kazakhstan

Generic and innovative drugs market in CIS countries 2013 : Russia, Ukraine and Kazakhstan

Date Published: Apr 1 2013

Keep current with the changing CIS generic and innovative drug segments.
Survey conditions and track market development in Russian Ukraine and Kazakhstan to 2015.
Generic and innovative drug segments in CIS countries have played a huge role in supporting the pharmaceutical industry. Meanwhile, the effects of programmes such as Russia’s Pharma 2020, Kazakhstan’s GMP initiative and Ukraine’s updated reimbursement structure are visible in the marketplace.

$2,800.00
Oncology Pharmaceuticals Market in India 2011

Oncology Pharmaceuticals Market in India 2011

Date Published: Aug 4 2011

Oncology pharmaceuticals market in India, a leading segment of the overall pharmaceuticals market is the fourth largest in volume and eighth largest in value in the global market. Since cancer is the second largest cause of death in the country, the Indian market is characterized by a huge demand for cancer drugs. It is a highly fragmented market with a large number of foreign and domestic players.

$795.00
Anti-Diabetic Pharmaceuticals Market in India 2011

Anti-Diabetic Pharmaceuticals Market in India 2011

Date Published: Aug 25 2011

Anti-diabetic pharmaceuticals market in India is one of the most lucrative diabetes markets in the world. Since India is the second largest diabetic pool in the world after China, the Indian market is characterized by a huge demand for anti-diabetic drugs. It is a highly fragmented market with a large number of foreign and domestic players. The huge increase in the number of diabetes cases, introduction of newer and better drugs, increasing aging population and introduction of diabetes insurance policies is helping the market to grow.

$795.00

Shopping cart

0 Items $0.00
Market Research Special Offers
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianB. Braun, Cobham, fiserv, Harris, Wipro, AonMunich Re, Lotte Chemical, National Post, First Data